Capricor Therapeutics, Inc. · NASDAQ:CAPR
The Vanguard Group's stake in Capricor Therapeutics, Inc. fell to 4.95% (Schedule 13G/A)
Event Mar 31, 2025 · Filed Apr 30, 2025
The Vanguard Group's stake in Capricor Therapeutics, Inc. fell to 4.95%, 2,263,991 shares, as a passive investor on Mar 31, 2025. Filed Apr 30, 2025 (Schedule 13G/A).
- Stake
- 4.95%
- Shares
- 2,263,991
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 4.95% | 2,263,991 |
Source
Related
- Capricor Therapeutics, Inc.
- The Vanguard Group
- Capricor Therapeutics, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Oct 30, 2025
- Schedule 13G · The Vanguard Group · Jul 29, 2025
- Schedule 13G · The Vanguard Group · Jan 30, 2025
- Schedule 13G/A · Millennium Management LLC · Oct 14, 2026
- Schedule 13G · Millennium Management LLC · Sep 14, 2026
- Schedule 13G · Millennium Management LLC · Aug 19, 2026
- Schedule 13G/A · Tang Capital Management LLC · Aug 14, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026